Cover Image
市場調查報告書

全球蛋白質體學的實驗室自動化市場:預測與趨勢

Global Lab Automation in Proteomics Market - By Equipment, Software, Analyzers, Type, Application, Mode of Automation, Geography, Forecasts, Trends - (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 543579
出版日期 內容資訊 英文 94 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球蛋白質體學的實驗室自動化市場:預測與趨勢 Global Lab Automation in Proteomics Market - By Equipment, Software, Analyzers, Type, Application, Mode of Automation, Geography, Forecasts, Trends - (2017 - 2022)
出版日期: 2017年01月30日 內容資訊: 英文 94 Pages
簡介

本報告提供全球蛋白質體學的實驗室自動化市場相關調查分析,市場概要,市場動態,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 主要調查結果

第3章 市場概要

  • 市場區隔
  • 概要
  • 產業價值鏈分析
  • 波特的五力分析

第4章 市場動態

  • 簡介
  • 推動因素
  • 阻礙因素

第5章 技術概要

  • 技術概述
  • 工業利用

第6章 實驗室自動化的設備

  • 自動液體處理器
  • 自動板處理器
  • 機械臂
  • 自動保管、搜索系統 (ASRS)

第7章 市場分析與預測

  • 各設備
  • 軟體
  • 分析設備
  • 盤式分析儀:各類型
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他

第8章 競爭情形

  • M&A
  • 合資企業
  • 新產品銷售
  • 5大企業:各收益
  • 最活躍的企業 (過去3年)

第9章 企業簡介

  • Thermo Scientific
  • Danaher
  • Hudson Robotics
  • Beckton Dickinson
  • Synchron Lab
  • Agilent Technologies
  • Siemens Healthcare
  • Tecan Group Ltd
  • PerkinElmer
  • Honeywell
  • BioRad
  • Roche Holding Ag
  • Eppendorf Ag
  • 島津製作所
  • Aurora Biomed

第10章 附錄

目錄

The Global Lab Automation in Proteomics market is valued at USD XX.XX billion in 2016 and is expected to reach a value of USD XX.XX billion by the end of 2022, growing at a projected CAGR of XX.XX% during the forecast period of 2017 - 2022. Automation is used in a wide variety of life science applications ranging from proteomics to systems biology. Automation is a dominant feature in the diagnostics market followed by the discovery and research labs. In clinical diagnostics, where profits are based on the number of samples, high throughput is the core driving factor. Total automation is generally preferred in such labs and manufacturing setups. Research labs and academic institutions are generally opting for modular automation, wherein they reduce the human intervention in tedious and repetitive tasks.

Researchers rely more on modern automated systems and robotics to find therapeutic targets in the proteome. Automated gel electrophoresis and mass spectrometry are the key areas that can be automated in a proteomics laboratory. The emergence of robotics has transformed the typical workday for scientists around the world. With the advent of automation techniques, scientists are now able to set up, run and analyze the results of experiments in a fraction of the time they needed in the past. In today's world, pulling maximum efficiency out of every department, including the R & D labs, is a major issue.

Automation of routine laboratory procedures, by the use of dedicated work stations and software to program instruments, allows associate scientists and technicians to think creatively about the implications of their experiments and to design effective follow-up projects or develop alternative approaches to their work instead of spending their days repeating tedious tasks.

Apart from reducing mundane tasks, the market for laboratory automation is also driven by the need for consistency in quality. Because, the cost of an error is very high in a scientific paper or developing a drug, even fairly low error rates can have a profound impact on the conclusions you make downstream.

It is believed that taking out the human element helps in achieving more consistency. Great advances have been made in the molding of plastics that has reduced the volumes of reagents used and enabled handling of smaller liquid volumes easy. These advancements have worked in favor of the development of micro and nano-litre plates to fit in with the automated liquid handling equipment.

Validation and data quality play a major role in modern life science. Legal validation, patents, and clinical testing have become crucial issues. Automation enables a much higher reproducibility and better documentation of data. This allows the production of more data points with great ease. It also ensures the safety of personnel in the presence of infectious or potentially hazardous material. North America is clearly the market leader with a total market share of 60%, followed by Europe. Asia and Latin America are emerging as there has been a considerable increase in outsourcing pharmaceutical manufacturing to these regions due to the availability of cheaper labor and resources.

This report analyzes the market across various geographies with the key trends in each region. It provides the market share and profiles of the top companies involved in lab automation. The report also provides insights on how the market will vary within the next five years.

DRIVERS:

  • Advancement in plastic molding technology
  • Development of smaller automated machines
  • Need for higher reproducibility and effective management of the vast amounts of data generated

RESTRAINTS:

  • Initial setup is expensive
  • Loss of flexibility in process
  • Interconnecting various platforms across the lab

Key Deliverables in the Study:

Market analysis for the global lab automation in proteomics market, with region-specific assessments and competition analysis on a global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the global lab automation in proteomics market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights into the major countries/regions where this industry is growing and also identify the regions that are still untapped.

Table of Contents

1. INTRODUCTION

  • 1.1 Research Methodology
    • 1.1.1 Definition of the Market
    • 1.1.2 Report Description
    • 1.1.3 Executive Summary

2. KEY FINDINGS OF THE STUDY

3. MARKET OVERVIEW

  • 3.1 Market Segmentation
  • 3.2 Overview
  • 3.3 Industry Value-Chain Analysis
  • 3.4 Industry Attractiveness - Porter's Five Forces Analysis

4. MARKET DYNAMICS

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Advancement in Plastic Molding Technology
    • 4.2.2 Development of Smaller Automated Machines
    • 4.2.3 Need for Higher Reproducibility and Effective Management of the Vast Amounts of Data Generated
  • 4.3 Constraints
    • 4.3.1 Initial Setup is Expensive
    • 4.3.2 Loss of Flexibility in Process
    • 4.3.3 Interconnecting Various Platforms Across the Lab

5. Technology Overview

  • 5.1 Technology Snapshot
  • 5.2 Industry Applications

6. Different Equipment in Lab Automation

  • 6.1 Automated Liquid Handlers
  • 6.2 Automated Plate Handlers
  • 6.3 Robotic Arms
  • 6.4 Automated Storage & Retrieval Systems (ASRS)

7. MARKET ANALYSIS AND FORECAST

  • 7.1 Global Market Segmented by Equipment
    • 7.1.1 Automated Liquid Handlers
    • 7.1.2 Automated Plate Handlers
    • 7.1.3 Robotic Arms
    • 7.1.4 Automated Storage & Retrieval Systems (ASRS)
  • 7.2 Global Software Market
    • 7.2.1 Laboratory Information Management System (LIMS)
    • 7.2.2 Laboratory Information System (LIS)
    • 7.2.3 Chromatography Data System (CDS)
    • 7.2.4 Electronic Lab Notebook (ELN)
    • 7.2.5 Scientific Data Management System (SDMS)
  • 7.3 Global Analyzer Market
    • 7.3.1 Biochemistry Analyzers
    • 7.3.2 Immuno-based Analyzers
    • 7.3.3 Hematology Analyzers
      • 7.3.3.1 Cell Counters
      • 7.3.3.2 Coulometers
  • 7.4 Global Plate Readers Market - Segmented by Type
    • 7.4.1 Absorbance
    • 7.4.2 Fluorescence
    • 7.4.3 Luminescence
    • 7.4.4 Time-resolved Fluorescence
    • 7.4.5 Fluorescence Polarization
    • 7.4.6 Light Scattering
  • 7.5 Global Market - Segmented By Region
    • 7.5.1 North America
      • 7.5.1.1 USA
      • 7.5.1.2 Canada
      • 7.5.1.3 Others
    • 7.5.2 Europe
      • 7.5.2.1 Germany
      • 7.5.2.2 United Kingdom
      • 7.5.2.3 Spain
      • 7.5.2.4 Others
    • 7.5.3 APAC
      • 7.5.3.1 Japan
      • 7.5.3.2 China
      • 7.5.3.3 South Korea
      • 7.5.3.4 Others
    • 7.5.4 ROW

8. Competitive Landscape

  • 8.1 Mergers & Acquisitions
  • 8.2 Joint Ventures
  • 8.3 New Product Launches
  • 8.4 Five Biggest Companies by Revenue
  • 8.5 Two Most Active Companies in the Past Three Years

9. Company Profiles

  • 9.1 Thermo Scientific
    • 9.1.1 Overview
    • 9.1.2 Major Products and Services
    • 9.1.3 Financials
    • 9.1.4 Recent Developments
  • 9.2 Danaher
    • 9.2.1 Overview
    • 9.2.2 Major Products and Services
    • 9.2.3 Financials
    • 9.2.4 Recent Developments
  • 9.3 Hudson Robotics
    • 9.3.1 Overview
    • 9.3.2 Major Products and Services
    • 9.3.3 Financials
    • 9.3.4 Recent Developments
  • 9.4 Beckton Dickinson
    • 9.4.1 Overview
    • 9.4.2 Major Products and Services
    • 9.4.3 Financials
    • 9.4.4 Recent Developments
  • 9.5 Synchron Lab
    • 9.5.1 Overview
    • 9.5.2 Major Products and Services
    • 9.5.3 Financials
    • 9.5.4 Recent Developments
  • 9.6 Agilent Technologies
    • 9.6.1 Overview
    • 9.6.2 Major Products and Services
    • 9.6.3 Financials
    • 9.6.4 Recent Developments
  • 9.7 Siemens Healthcare
    • 9.7.1 Overview
    • 9.7.2 Major Products and Services
    • 9.7.3 Financials
    • 9.7.4 Recent Developments
  • 9.8 Tecan Group Ltd
    • 9.8.1 Overview
    • 9.8.2 Major Products and Services
    • 9.8.3 Financials
    • 9.8.4 Recent Developments
  • 9.9 PerkinElmer
    • 9.9.1 Overview
    • 9.9.2 Major Products and Services
    • 9.9.3 Financials
    • 9.9.4 Recent Developments
  • 9.10 Honeywell
    • 9.10.1 Overview
    • 9.10.2 Major Products and Services
    • 9.10.3 Financials
    • 9.10.4 Recent Developments
  • 9.11 BioRad
    • 9.11.1 Overview
    • 9.11.2 Major Products and Services
    • 9.11.3 Financials
    • 9.11.4 Recent Developments
  • 9.12 Roche Holding Ag
    • 9.12.1 Overview
    • 9.12.2 Major Products and Services
    • 9.12.3 Financials
    • 9.12.4 Recent Developments
  • 9.13 Eppendorf Ag
    • 9.13.1 Overview
    • 9.13.2 Major Products and Services
    • 9.13.3 Financials
    • 9.13.4 Recent Developments
  • 9.14 Shimadzu
    • 9.14.1 Overview
    • 9.14.2 Major Products and Services
    • 9.14.3 Financials
    • 9.14.4 Recent Developments
  • 9.15 Aurora Biomed
    • 9.15.1 Overview
    • 9.15.2 Major Products and Services
    • 9.15.3 Financials
    • 9.15.4 Recent Developments

10. Appendix

  • 10.1 Abbreviations
  • 10.2 Sources
  • 10.3 Bibliography
  • 10.4 Disclaimer
Back to Top